GlassScriptPhysician profile
Joseph A Franklin
NPI 1730101213
$53,943.23
in general payments reported to CMS, 2019-2025
18 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,616 · 2020: $494 · 2021: $488 · 2022: $10K · 2023: $3,122 · 2024: $17K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Food and Beverage: $1,430 · Travel and Lodging: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,500.00 |
| Food and Beverage | $1,430.07 |
| Travel and Lodging | $1,230.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $47,559.68 | 2019-2025 | Xeomin |
| Biotissue Holdings INC. | $1,582.41 | 2024 | |
| Sientra, INC. | $940.19 | 2021-2022 | |
| Stryker Corporation | $885.00 | 2022 | |
| Medical Device Business Services, INC. | $870.14 | 2019 | |
| Medtronic, INC. | $401.08 | 2022 | |
| Allergan, INC. | $324.93 | 2019-2022 | |
| Integra Lifesciences Corporation | $265.81 | 2020-2023 | Integra, Integra Dermal Regeneration Template |
| Galderma Laboratories, L.P. | $202.28 | 2019-2025 | |
| Smith+Nephew, INC. | $178.81 | 2022-2025 | Renasys Touch |
| Mentor Worldwide LLC | $170.23 | 2021 | |
| Abbvie INC. | $160.83 | 2023 | |
| Normatec Industries, LP | $156.38 | 2019 | |
| Boston Scientific Corporation | $85.41 | 2025 | Wavewriter Alpha Prime 16 |
| Motiva USA, LLC | $75.00 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $37.38 | 2023 | |
| Revance Therapeutics, INC. | $27.81 | 2024 | Daxxify |
| Aroa Biosurgery Incorporated | $19.86 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.